Clinical Trials Directory

Trials / Unknown

UnknownNCT06194396

Effect of Chlorhexidine Versus Alcohol on Infections in Neonates

Effect of Chlorhexidine 2% Versus Alcohol on Healthcare Associated Infections in Neonates: Randomized Control Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
28 Days
Healthy volunteers
Not accepted

Summary

Chlorhexidine is a local antiseptic that has an important role in the prevention of catheter-associated bloodstream infections. Its application to a newborn's umbilical cord reduces all-cause neonatal mortality.

Detailed description

Skin disinfection by an appropriate antiseptic agent is essential to prevent healthcare-associated infection. Common pathogens responsible for sepsis have been detected in skin microbiota of hospitalized neonates. Such skin inhabitants can cause sepsis and also lead to blood culture contamination resulting in unnecessary antibiotic use. Strict asepsis bundles have been shown to reduce catheter-related blood stream infection (CRBSI) and contamination rates. The choice of appropriate skin disinfectant is, however, based on low-quality evidence, even in adults. Chlorhexidine gluconate (CHG) is a broad-spectrum antiseptic which is effective against a host of neonatal pathogens. CHG-based products are used frequently in the healthcare setting for peripheral and central venous catheter (CVC) site skin preparation, daily bathing of intensive care unit patients, full-body newborn skin cleansing, umbilical cord care, and Staphylococcus aureus decolonization. In neonates, CHG used as antiseptic for CVC insertion site preparation and maintenance decreases CVC tip microbial colonization. Trials of full-body skin cleansing and umbilical cord care with CHG in the developing world, which included infants less than 34 weeks gestational age, have demonstrated reduced risk of neonatal mortality. Despite proven efficacy of CHG in neonates, current guidelines acknowledge that no recommendations with regards to CHG antisepsis can be made for infants less than 2 months of age due to incomplete safety data in this population.

Conditions

Interventions

TypeNameDescription
OTHERchlorhexidinechlorhexidine will be used as skin disinfectant before insertion of CVC, PICC line, and umbilical catheter
OTHERalcoholalcohol will be used as skin disinfectant before insertion of CVC ,PICC line and umbilical catheter

Timeline

Start date
2023-05-01
Primary completion
2024-04-01
Completion
2024-07-01
First posted
2024-01-08
Last updated
2024-03-12

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06194396. Inclusion in this directory is not an endorsement.